These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
526 related articles for article (PubMed ID: 27986595)
21. Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation. Xie L; Song X; Guo W; Wang X; Wei L; Li Y; Lv L; Wang W; Chen TC; Song X Oncotarget; 2016 Jan; 7(2):1651-62. PubMed ID: 26625208 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of JNK potentiates temozolomide-induced cytotoxicity in U87MG glioblastoma cells via suppression of Akt phosphorylation. Vo VA; Lee JW; Lee HJ; Chun W; Lim SY; Kim SS Anticancer Res; 2014 Oct; 34(10):5509-15. PubMed ID: 25275048 [TBL] [Abstract][Full Text] [Related]
23. Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway. Gielen PR; Aftab Q; Ma N; Chen VC; Hong X; Lozinsky S; Naus CC; Sin WC Neuropharmacology; 2013 Dec; 75():539-48. PubMed ID: 23688923 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways. Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257 [TBL] [Abstract][Full Text] [Related]
25. Temozolomide-modulated glioma proteome: role of interleukin-1 receptor-associated kinase-4 (IRAK4) in chemosensitivity. Kumar DM; Patil V; Ramachandran B; Nila MV; Dharmalingam K; Somasundaram K Proteomics; 2013 Jul; 13(14):2113-24. PubMed ID: 23595970 [TBL] [Abstract][Full Text] [Related]
26. The PI3K inhibitor GDC-0941 enhances radiosensitization and reduces chemoresistance to temozolomide in GBM cell lines. Shi F; Guo H; Zhang R; Liu H; Wu L; Wu Q; Liu J; Liu T; Zhang Q Neuroscience; 2017 Mar; 346():298-308. PubMed ID: 28147244 [TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100Hz, 100G). Akbarnejad Z; Eskandary H; Dini L; Vergallo C; Nematollahi-Mahani SN; Farsinejad A; Abadi MFS; Ahmadi M Biomed Pharmacother; 2017 Aug; 92():254-264. PubMed ID: 28551545 [TBL] [Abstract][Full Text] [Related]
28. Pyrimethamine sensitizes pituitary adenomas cells to temozolomide through cathepsin B-dependent and caspase-dependent apoptotic pathways. Dai C; Zhang B; Liu X; Guo K; Ma S; Cai F; Yang Y; Yao Y; Feng M; Bao X; Deng K; Jiao Y; Wei Z; Junji W; Xing B; Lian W; Wang R Int J Cancer; 2013 Oct; 133(8):1982-93. PubMed ID: 23564480 [TBL] [Abstract][Full Text] [Related]
29. Temozolomide induces autophagy via ATM‑AMPK‑ULK1 pathways in glioma. Zou Y; Wang Q; Li B; Xie B; Wang W Mol Med Rep; 2014 Jul; 10(1):411-6. PubMed ID: 24737504 [TBL] [Abstract][Full Text] [Related]
30. Temozolomide sensitizes stem-like cells of glioma spheres to TRAIL-induced apoptosis via upregulation of casitas B-lineage lymphoma (c-Cbl) protein. Zhitao J; Long L; Jia L; Yunchao B; Anhua W Tumour Biol; 2015 Dec; 36(12):9621-30. PubMed ID: 26142735 [TBL] [Abstract][Full Text] [Related]
31. miR-140 targeting CTSB signaling suppresses the mesenchymal transition and enhances temozolomide cytotoxicity in glioblastoma multiforme. Ho KH; Cheng CH; Chou CM; Chen PH; Liu AJ; Lin CW; Shih CM; Chen KC Pharmacol Res; 2019 Sep; 147():104390. PubMed ID: 31398406 [TBL] [Abstract][Full Text] [Related]
32. LY294002 enhances cytotoxicity of temozolomide in glioma by down-regulation of the PI3K/Akt pathway. Chen L; Han L; Shi Z; Zhang K; Liu Y; Zheng Y; Jiang T; Pu P; Jiang C; Kang C Mol Med Rep; 2012 Feb; 5(2):575-9. PubMed ID: 22086271 [TBL] [Abstract][Full Text] [Related]
33. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma. Lan F; Pan Q; Yu H; Yue X J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372 [TBL] [Abstract][Full Text] [Related]
34. Non-thermal atmospheric plasma induces ROS-independent cell death in U373MG glioma cells and augments the cytotoxicity of temozolomide. Conway GE; Casey A; Milosavljevic V; Liu Y; Howe O; Cullen PJ; Curtin JF Br J Cancer; 2016 Feb; 114(4):435-43. PubMed ID: 26882067 [TBL] [Abstract][Full Text] [Related]
35. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line. Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449 [TBL] [Abstract][Full Text] [Related]
36. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway. Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746 [TBL] [Abstract][Full Text] [Related]
37. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway. Xu P; Zhang G; Hou S; Sha LG Biomed Pharmacother; 2018 Oct; 106():1419-1427. PubMed ID: 30119215 [TBL] [Abstract][Full Text] [Related]
38. Fluoxetine synergizes with temozolomide to induce the CHOP-dependent endoplasmic reticulum stress-related apoptosis pathway in glioma cells. Ma J; Yang YR; Chen W; Chen MH; Wang H; Wang XD; Sun LL; Wang FZ; Wang DC Oncol Rep; 2016 Aug; 36(2):676-84. PubMed ID: 27278525 [TBL] [Abstract][Full Text] [Related]
39. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists. Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057 [TBL] [Abstract][Full Text] [Related]
40. Activation of AMP-activated protein kinase by temozolomide contributes to apoptosis in glioblastoma cells via p53 activation and mTORC1 inhibition. Zhang WB; Wang Z; Shu F; Jin YH; Liu HY; Wang QJ; Yang Y J Biol Chem; 2010 Dec; 285(52):40461-71. PubMed ID: 20880848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]